Zhenkun Lou
Impact in
- Geriatrics and Gerontology top 0.2%
- Sirtuins and Resveratrol in Medicine
- Oncology top 0.5%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Papers in
-
- Sirtuins and Resveratrol in Medicine 14
- Oncology 59
- Cancer-related Molecular Pathways 29
- PARP inhibition in cancer therapy 20
- Co-authors
- Junjie ChenJian YuanKuntian LuoKatherine Minter‐DykhouseLiewei WangJa‐Eun KimSomaira NowsheenBo Qin
- Journals
- Nature Communications (9 papers)Nucleic Acids Research (9 papers)Journal of Biological Chemistry (7 papers)Molecular Cell (7 papers)The Journal of Immunology (5 papers)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Zhenkun Lou
123 papers receiving 8.9k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Geriatrics and Gerontology 936
- Oncology 2.8k
- Molecular Biology 6.8k
- Cancer Research 1.4k
- Aging 132
Countries citing papers authored by Zhenkun Lou
This map shows the geographic impact of Zhenkun Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenkun Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenkun Lou more than expected).
Fields of papers citing papers by Zhenkun Lou
This network shows the impact of papers produced by Zhenkun Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenkun Lou. The network helps show where Zhenkun Lou may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenkun Lou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 14 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 20 | |
| 9 | 2021 | 30 | |
| 10 | 2020 | 71 | |
| 11 | 2020 | 25 | |
| 12 | 2020 | 91 | |
| 13 | 2020 | 42 | |
| 14 | 2018 | 71 | |
| 15 | 2018 | 20 | |
| 16 | 2017 | 2 | |
| 17 | 2015 | 71 | |
| 18 | 2015 | 33 | |
| 19 | 2009 | 191 | |
| 20 | 2006 | 279 |
About Zhenkun Lou
Zhenkun Lou is a scholar working on Geriatrics and Gerontology, Oncology, Molecular Biology, Aging and Cancer Research, having authored 134 papers that have together received 9.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (66 papers), Cancer-related Molecular Pathways (29 papers), Ubiquitin and proteasome pathways (26 papers), PARP inhibition in cancer therapy (20 papers), Sirtuins and Resveratrol in Medicine (14 papers), CRISPR and Genetic Engineering (12 papers), Autophagy in Disease and Therapy (10 papers) and Microtubule and mitosis dynamics (9 papers). The work is most often cited by research in Geriatrics and Gerontology (936 citations), Oncology (2.8k citations), Molecular Biology (6.8k citations), Cancer Research (1.4k citations) and Aging (132 citations). Zhenkun Lou has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Junjie Chen, Jian Yuan, Kuntian Luo, Katherine Minter‐Dykhouse, Liewei Wang, Ja‐Eun Kim, Somaira Nowsheen, Bo Qin, Lizhi Zhang and John C. Cheville. Their work appears in journals such as Nature Communications, Nucleic Acids Research, Journal of Biological Chemistry, Molecular Cell and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.